Glutathione, glutathione‐dependent enzymes and antioxidant status in erythrocytes from children treated with high‐dose paracetamol

Aim To investigate glutathione and antioxidant status changes in erythrocytes from febrile children receiving repeated supratherapeutic paracetamol doses. Methods Fifty‐one children aged 2 months to 10 years participated in the study. Three groups were studied: group 1 (n = 24) included afebrile chi...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:British journal of clinical pharmacology 2003-03, Vol.55 (3), p.234-240
Hauptverfasser: Kozer, Eran, Evans, Sandra, Barr, Joseph, Greenberg, Revital, Soriano, Ingrid, Bulkowstein, Mordechai, Petrov, Irena, Chen‐Levi, Zehava, Barzilay, Bernard, Berkovitch, Matitiahu
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 240
container_issue 3
container_start_page 234
container_title British journal of clinical pharmacology
container_volume 55
creator Kozer, Eran
Evans, Sandra
Barr, Joseph
Greenberg, Revital
Soriano, Ingrid
Bulkowstein, Mordechai
Petrov, Irena
Chen‐Levi, Zehava
Barzilay, Bernard
Berkovitch, Matitiahu
description Aim To investigate glutathione and antioxidant status changes in erythrocytes from febrile children receiving repeated supratherapeutic paracetamol doses. Methods Fifty‐one children aged 2 months to 10 years participated in the study. Three groups were studied: group 1 (n = 24) included afebrile children who did not receive paracetamol; and groups 2 (n = 13) and 3 (n = 14) included children who had fever above 38.5°C for more than 72 h. Patients in group 2 received paracetamol at a dose of 50 ± 15 (30–75) mg kg−1 day−1 and those in group 3 received paracetamol above the recommended therapeutic dose, ie 107 ± 28 (80–180) mg kg−1 day−1. A blood sample was taken for the measurement of liver transaminases, gammaglutamil transferase (GGT), reduced glutathione (GSH), glutathione reductase (GR), glutathione peroxidase (GPX), glutathione S‐transferase (GST), superoxide dismutase (SOD) and antioxidant status. Results Aspartate aminotransferase activity in group 3 was higher than in the other groups (P = 0.027). GSH, SOD and antioxidant status were significantly lower in group 3 compared with groups 1 and 2 (mean differences: for GSH 3.41 µmol gHb−1, 95% confidence interval (CI) 2.10–4.72, and 2.15 µmol gHb−1, 95% CI 0.65–3.65, respectively; for SOD 856 U min−1 gHb−1, 95% CI 397–1316, and 556 U min−1 gHb−1, 95% CI 30–1082, respectively; and for antioxidant status 0.83 mmol l−1 plasma, 95% CI 0.30–1.36, and 0.63 mmol l−1 plasma, 95% CI 0.02–1.24, respectively). GR activity was significantly lower in groups 3 and 2 in comparison with group 1 (mean differences 3.44 U min−1 gHb−1, 95% CI 0.63–6.25, and 5.64 U min−1 gHb−1, 95% CI 2.90–8.38, respectively). Using multiple regression analysis, paracetamol dose was found to be the only independent variable affecting GR, GST and SOD activities (P = 0.007, 0.003 and 0.008, respectively). Conclusions In febrile children, treatment with repeated supratherapeutic doses of paracetamol is associated with reduced antioxidant status and erythrocyte glutathione concentrations. These significant changes may indicate an increased risk for hepatotoxicity and liver damage.
doi_str_mv 10.1046/j.1365-2125.2003.01723.x
format Article
fullrecord <record><control><sourceid>wiley_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_1884208</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>BCP1723</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4713-511bdfb4389b458b121a959c8ab95ddbbae086114317b6531a006f38fb77762c3</originalsourceid><addsrcrecordid>eNqNkU-P1CAYh4nRuOPqVzBcvNnKCwXagyY6WVeTTfSgZwKUTpn0zwQYd-rJ0579jH4SW2eyozcP5IW8z_sD8iCEgeRACvFqmwMTPKNAeU4JYTkBSVl-eIBW942HaEUYERmnHC7Qkxi3hAADwR-jC6CCkUrSFbq77vZJp9aPg3uJN-fDrx8_a7dzQ-2GhN3wfepdxHqo55X8ePD1XHGc6X3EfsAuTKkNo53SjDVh7LFtfVcHN-AUnE6uxrc-tbj1m3aJHqPDOx20dUn3Y_cUPWp0F92zU71EX99ffVl_yG4-XX9cv73JbCGBZRzA1I0pWFmZgpcGKOiKV7bUpuJ1bYx2pBQABQNpBGegCRENKxsjpRTUskv05pi725ve1Xb-XNCd2gXf6zCpUXv1b2fwrdqM3xSUZUFJOQeUxwAbxhiDa-5ngajFjdqqRYFaFKjFjfrjRh3m0ed_330ePMmYgRcnQEeruybowfp45grBpKzkzL0-cre-c9N_P0C9W39eduw3qxexIg</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Glutathione, glutathione‐dependent enzymes and antioxidant status in erythrocytes from children treated with high‐dose paracetamol</title><source>MEDLINE</source><source>Wiley Online Library Free Content</source><source>Access via Wiley Online Library</source><source>EZB-FREE-00999 freely available EZB journals</source><source>Alma/SFX Local Collection</source><creator>Kozer, Eran ; Evans, Sandra ; Barr, Joseph ; Greenberg, Revital ; Soriano, Ingrid ; Bulkowstein, Mordechai ; Petrov, Irena ; Chen‐Levi, Zehava ; Barzilay, Bernard ; Berkovitch, Matitiahu</creator><creatorcontrib>Kozer, Eran ; Evans, Sandra ; Barr, Joseph ; Greenberg, Revital ; Soriano, Ingrid ; Bulkowstein, Mordechai ; Petrov, Irena ; Chen‐Levi, Zehava ; Barzilay, Bernard ; Berkovitch, Matitiahu</creatorcontrib><description>Aim To investigate glutathione and antioxidant status changes in erythrocytes from febrile children receiving repeated supratherapeutic paracetamol doses. Methods Fifty‐one children aged 2 months to 10 years participated in the study. Three groups were studied: group 1 (n = 24) included afebrile children who did not receive paracetamol; and groups 2 (n = 13) and 3 (n = 14) included children who had fever above 38.5°C for more than 72 h. Patients in group 2 received paracetamol at a dose of 50 ± 15 (30–75) mg kg−1 day−1 and those in group 3 received paracetamol above the recommended therapeutic dose, ie 107 ± 28 (80–180) mg kg−1 day−1. A blood sample was taken for the measurement of liver transaminases, gammaglutamil transferase (GGT), reduced glutathione (GSH), glutathione reductase (GR), glutathione peroxidase (GPX), glutathione S‐transferase (GST), superoxide dismutase (SOD) and antioxidant status. Results Aspartate aminotransferase activity in group 3 was higher than in the other groups (P = 0.027). GSH, SOD and antioxidant status were significantly lower in group 3 compared with groups 1 and 2 (mean differences: for GSH 3.41 µmol gHb−1, 95% confidence interval (CI) 2.10–4.72, and 2.15 µmol gHb−1, 95% CI 0.65–3.65, respectively; for SOD 856 U min−1 gHb−1, 95% CI 397–1316, and 556 U min−1 gHb−1, 95% CI 30–1082, respectively; and for antioxidant status 0.83 mmol l−1 plasma, 95% CI 0.30–1.36, and 0.63 mmol l−1 plasma, 95% CI 0.02–1.24, respectively). GR activity was significantly lower in groups 3 and 2 in comparison with group 1 (mean differences 3.44 U min−1 gHb−1, 95% CI 0.63–6.25, and 5.64 U min−1 gHb−1, 95% CI 2.90–8.38, respectively). Using multiple regression analysis, paracetamol dose was found to be the only independent variable affecting GR, GST and SOD activities (P = 0.007, 0.003 and 0.008, respectively). Conclusions In febrile children, treatment with repeated supratherapeutic doses of paracetamol is associated with reduced antioxidant status and erythrocyte glutathione concentrations. These significant changes may indicate an increased risk for hepatotoxicity and liver damage.</description><identifier>ISSN: 0306-5251</identifier><identifier>EISSN: 1365-2125</identifier><identifier>DOI: 10.1046/j.1365-2125.2003.01723.x</identifier><identifier>PMID: 12630972</identifier><identifier>CODEN: BCPHBM</identifier><language>eng</language><publisher>Oxford, UK: Blackwell Science Ltd</publisher><subject>Acetaminophen - administration &amp; dosage ; antioxidant status ; Antioxidants - metabolism ; Biological and medical sciences ; Child ; Child, Preschool ; Clinical Toxicology ; Drug toxicity and drugs side effects treatment ; Erythrocytes - enzymology ; febrile children ; Female ; Glutathione - metabolism ; glutathione changes ; Glutathione Peroxidase - blood ; Glutathione Reductase - blood ; Glutathione Transferase - blood ; glutathione‐dependent enzymes ; Humans ; Infant ; Male ; Medical sciences ; Pharmacology. Drug treatments ; Prospective Studies ; repeated paracetamol ; Superoxide Dismutase - blood ; Toxicity: digestive system</subject><ispartof>British journal of clinical pharmacology, 2003-03, Vol.55 (3), p.234-240</ispartof><rights>2003 INIST-CNRS</rights><rights>2003 Blackwell Publishing Ltd 2003</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4713-511bdfb4389b458b121a959c8ab95ddbbae086114317b6531a006f38fb77762c3</citedby><cites>FETCH-LOGICAL-c4713-511bdfb4389b458b121a959c8ab95ddbbae086114317b6531a006f38fb77762c3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1046%2Fj.1365-2125.2003.01723.x$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1046%2Fj.1365-2125.2003.01723.x$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>230,314,780,784,885,1417,1433,27924,27925,45574,45575,46409,46833</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=14637797$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/12630972$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Kozer, Eran</creatorcontrib><creatorcontrib>Evans, Sandra</creatorcontrib><creatorcontrib>Barr, Joseph</creatorcontrib><creatorcontrib>Greenberg, Revital</creatorcontrib><creatorcontrib>Soriano, Ingrid</creatorcontrib><creatorcontrib>Bulkowstein, Mordechai</creatorcontrib><creatorcontrib>Petrov, Irena</creatorcontrib><creatorcontrib>Chen‐Levi, Zehava</creatorcontrib><creatorcontrib>Barzilay, Bernard</creatorcontrib><creatorcontrib>Berkovitch, Matitiahu</creatorcontrib><title>Glutathione, glutathione‐dependent enzymes and antioxidant status in erythrocytes from children treated with high‐dose paracetamol</title><title>British journal of clinical pharmacology</title><addtitle>Br J Clin Pharmacol</addtitle><description>Aim To investigate glutathione and antioxidant status changes in erythrocytes from febrile children receiving repeated supratherapeutic paracetamol doses. Methods Fifty‐one children aged 2 months to 10 years participated in the study. Three groups were studied: group 1 (n = 24) included afebrile children who did not receive paracetamol; and groups 2 (n = 13) and 3 (n = 14) included children who had fever above 38.5°C for more than 72 h. Patients in group 2 received paracetamol at a dose of 50 ± 15 (30–75) mg kg−1 day−1 and those in group 3 received paracetamol above the recommended therapeutic dose, ie 107 ± 28 (80–180) mg kg−1 day−1. A blood sample was taken for the measurement of liver transaminases, gammaglutamil transferase (GGT), reduced glutathione (GSH), glutathione reductase (GR), glutathione peroxidase (GPX), glutathione S‐transferase (GST), superoxide dismutase (SOD) and antioxidant status. Results Aspartate aminotransferase activity in group 3 was higher than in the other groups (P = 0.027). GSH, SOD and antioxidant status were significantly lower in group 3 compared with groups 1 and 2 (mean differences: for GSH 3.41 µmol gHb−1, 95% confidence interval (CI) 2.10–4.72, and 2.15 µmol gHb−1, 95% CI 0.65–3.65, respectively; for SOD 856 U min−1 gHb−1, 95% CI 397–1316, and 556 U min−1 gHb−1, 95% CI 30–1082, respectively; and for antioxidant status 0.83 mmol l−1 plasma, 95% CI 0.30–1.36, and 0.63 mmol l−1 plasma, 95% CI 0.02–1.24, respectively). GR activity was significantly lower in groups 3 and 2 in comparison with group 1 (mean differences 3.44 U min−1 gHb−1, 95% CI 0.63–6.25, and 5.64 U min−1 gHb−1, 95% CI 2.90–8.38, respectively). Using multiple regression analysis, paracetamol dose was found to be the only independent variable affecting GR, GST and SOD activities (P = 0.007, 0.003 and 0.008, respectively). Conclusions In febrile children, treatment with repeated supratherapeutic doses of paracetamol is associated with reduced antioxidant status and erythrocyte glutathione concentrations. These significant changes may indicate an increased risk for hepatotoxicity and liver damage.</description><subject>Acetaminophen - administration &amp; dosage</subject><subject>antioxidant status</subject><subject>Antioxidants - metabolism</subject><subject>Biological and medical sciences</subject><subject>Child</subject><subject>Child, Preschool</subject><subject>Clinical Toxicology</subject><subject>Drug toxicity and drugs side effects treatment</subject><subject>Erythrocytes - enzymology</subject><subject>febrile children</subject><subject>Female</subject><subject>Glutathione - metabolism</subject><subject>glutathione changes</subject><subject>Glutathione Peroxidase - blood</subject><subject>Glutathione Reductase - blood</subject><subject>Glutathione Transferase - blood</subject><subject>glutathione‐dependent enzymes</subject><subject>Humans</subject><subject>Infant</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Pharmacology. Drug treatments</subject><subject>Prospective Studies</subject><subject>repeated paracetamol</subject><subject>Superoxide Dismutase - blood</subject><subject>Toxicity: digestive system</subject><issn>0306-5251</issn><issn>1365-2125</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2003</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqNkU-P1CAYh4nRuOPqVzBcvNnKCwXagyY6WVeTTfSgZwKUTpn0zwQYd-rJ0579jH4SW2eyozcP5IW8z_sD8iCEgeRACvFqmwMTPKNAeU4JYTkBSVl-eIBW942HaEUYERmnHC7Qkxi3hAADwR-jC6CCkUrSFbq77vZJp9aPg3uJN-fDrx8_a7dzQ-2GhN3wfepdxHqo55X8ePD1XHGc6X3EfsAuTKkNo53SjDVh7LFtfVcHN-AUnE6uxrc-tbj1m3aJHqPDOx20dUn3Y_cUPWp0F92zU71EX99ffVl_yG4-XX9cv73JbCGBZRzA1I0pWFmZgpcGKOiKV7bUpuJ1bYx2pBQABQNpBGegCRENKxsjpRTUskv05pi725ve1Xb-XNCd2gXf6zCpUXv1b2fwrdqM3xSUZUFJOQeUxwAbxhiDa-5ngajFjdqqRYFaFKjFjfrjRh3m0ed_330ePMmYgRcnQEeruybowfp45grBpKzkzL0-cre-c9N_P0C9W39eduw3qxexIg</recordid><startdate>200303</startdate><enddate>200303</enddate><creator>Kozer, Eran</creator><creator>Evans, Sandra</creator><creator>Barr, Joseph</creator><creator>Greenberg, Revital</creator><creator>Soriano, Ingrid</creator><creator>Bulkowstein, Mordechai</creator><creator>Petrov, Irena</creator><creator>Chen‐Levi, Zehava</creator><creator>Barzilay, Bernard</creator><creator>Berkovitch, Matitiahu</creator><general>Blackwell Science Ltd</general><general>Blackwell Science</general><general>Blackwell Science Inc</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>5PM</scope></search><sort><creationdate>200303</creationdate><title>Glutathione, glutathione‐dependent enzymes and antioxidant status in erythrocytes from children treated with high‐dose paracetamol</title><author>Kozer, Eran ; Evans, Sandra ; Barr, Joseph ; Greenberg, Revital ; Soriano, Ingrid ; Bulkowstein, Mordechai ; Petrov, Irena ; Chen‐Levi, Zehava ; Barzilay, Bernard ; Berkovitch, Matitiahu</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4713-511bdfb4389b458b121a959c8ab95ddbbae086114317b6531a006f38fb77762c3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2003</creationdate><topic>Acetaminophen - administration &amp; dosage</topic><topic>antioxidant status</topic><topic>Antioxidants - metabolism</topic><topic>Biological and medical sciences</topic><topic>Child</topic><topic>Child, Preschool</topic><topic>Clinical Toxicology</topic><topic>Drug toxicity and drugs side effects treatment</topic><topic>Erythrocytes - enzymology</topic><topic>febrile children</topic><topic>Female</topic><topic>Glutathione - metabolism</topic><topic>glutathione changes</topic><topic>Glutathione Peroxidase - blood</topic><topic>Glutathione Reductase - blood</topic><topic>Glutathione Transferase - blood</topic><topic>glutathione‐dependent enzymes</topic><topic>Humans</topic><topic>Infant</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Pharmacology. Drug treatments</topic><topic>Prospective Studies</topic><topic>repeated paracetamol</topic><topic>Superoxide Dismutase - blood</topic><topic>Toxicity: digestive system</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Kozer, Eran</creatorcontrib><creatorcontrib>Evans, Sandra</creatorcontrib><creatorcontrib>Barr, Joseph</creatorcontrib><creatorcontrib>Greenberg, Revital</creatorcontrib><creatorcontrib>Soriano, Ingrid</creatorcontrib><creatorcontrib>Bulkowstein, Mordechai</creatorcontrib><creatorcontrib>Petrov, Irena</creatorcontrib><creatorcontrib>Chen‐Levi, Zehava</creatorcontrib><creatorcontrib>Barzilay, Bernard</creatorcontrib><creatorcontrib>Berkovitch, Matitiahu</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>British journal of clinical pharmacology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Kozer, Eran</au><au>Evans, Sandra</au><au>Barr, Joseph</au><au>Greenberg, Revital</au><au>Soriano, Ingrid</au><au>Bulkowstein, Mordechai</au><au>Petrov, Irena</au><au>Chen‐Levi, Zehava</au><au>Barzilay, Bernard</au><au>Berkovitch, Matitiahu</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Glutathione, glutathione‐dependent enzymes and antioxidant status in erythrocytes from children treated with high‐dose paracetamol</atitle><jtitle>British journal of clinical pharmacology</jtitle><addtitle>Br J Clin Pharmacol</addtitle><date>2003-03</date><risdate>2003</risdate><volume>55</volume><issue>3</issue><spage>234</spage><epage>240</epage><pages>234-240</pages><issn>0306-5251</issn><eissn>1365-2125</eissn><coden>BCPHBM</coden><abstract>Aim To investigate glutathione and antioxidant status changes in erythrocytes from febrile children receiving repeated supratherapeutic paracetamol doses. Methods Fifty‐one children aged 2 months to 10 years participated in the study. Three groups were studied: group 1 (n = 24) included afebrile children who did not receive paracetamol; and groups 2 (n = 13) and 3 (n = 14) included children who had fever above 38.5°C for more than 72 h. Patients in group 2 received paracetamol at a dose of 50 ± 15 (30–75) mg kg−1 day−1 and those in group 3 received paracetamol above the recommended therapeutic dose, ie 107 ± 28 (80–180) mg kg−1 day−1. A blood sample was taken for the measurement of liver transaminases, gammaglutamil transferase (GGT), reduced glutathione (GSH), glutathione reductase (GR), glutathione peroxidase (GPX), glutathione S‐transferase (GST), superoxide dismutase (SOD) and antioxidant status. Results Aspartate aminotransferase activity in group 3 was higher than in the other groups (P = 0.027). GSH, SOD and antioxidant status were significantly lower in group 3 compared with groups 1 and 2 (mean differences: for GSH 3.41 µmol gHb−1, 95% confidence interval (CI) 2.10–4.72, and 2.15 µmol gHb−1, 95% CI 0.65–3.65, respectively; for SOD 856 U min−1 gHb−1, 95% CI 397–1316, and 556 U min−1 gHb−1, 95% CI 30–1082, respectively; and for antioxidant status 0.83 mmol l−1 plasma, 95% CI 0.30–1.36, and 0.63 mmol l−1 plasma, 95% CI 0.02–1.24, respectively). GR activity was significantly lower in groups 3 and 2 in comparison with group 1 (mean differences 3.44 U min−1 gHb−1, 95% CI 0.63–6.25, and 5.64 U min−1 gHb−1, 95% CI 2.90–8.38, respectively). Using multiple regression analysis, paracetamol dose was found to be the only independent variable affecting GR, GST and SOD activities (P = 0.007, 0.003 and 0.008, respectively). Conclusions In febrile children, treatment with repeated supratherapeutic doses of paracetamol is associated with reduced antioxidant status and erythrocyte glutathione concentrations. These significant changes may indicate an increased risk for hepatotoxicity and liver damage.</abstract><cop>Oxford, UK</cop><pub>Blackwell Science Ltd</pub><pmid>12630972</pmid><doi>10.1046/j.1365-2125.2003.01723.x</doi><tpages>7</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0306-5251
ispartof British journal of clinical pharmacology, 2003-03, Vol.55 (3), p.234-240
issn 0306-5251
1365-2125
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_1884208
source MEDLINE; Wiley Online Library Free Content; Access via Wiley Online Library; EZB-FREE-00999 freely available EZB journals; Alma/SFX Local Collection
subjects Acetaminophen - administration & dosage
antioxidant status
Antioxidants - metabolism
Biological and medical sciences
Child
Child, Preschool
Clinical Toxicology
Drug toxicity and drugs side effects treatment
Erythrocytes - enzymology
febrile children
Female
Glutathione - metabolism
glutathione changes
Glutathione Peroxidase - blood
Glutathione Reductase - blood
Glutathione Transferase - blood
glutathione‐dependent enzymes
Humans
Infant
Male
Medical sciences
Pharmacology. Drug treatments
Prospective Studies
repeated paracetamol
Superoxide Dismutase - blood
Toxicity: digestive system
title Glutathione, glutathione‐dependent enzymes and antioxidant status in erythrocytes from children treated with high‐dose paracetamol
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-27T14%3A52%3A20IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-wiley_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Glutathione,%20glutathione%E2%80%90dependent%20enzymes%20and%20antioxidant%20status%20in%20erythrocytes%20from%20children%20treated%20with%20high%E2%80%90dose%20paracetamol&rft.jtitle=British%20journal%20of%20clinical%20pharmacology&rft.au=Kozer,%20Eran&rft.date=2003-03&rft.volume=55&rft.issue=3&rft.spage=234&rft.epage=240&rft.pages=234-240&rft.issn=0306-5251&rft.eissn=1365-2125&rft.coden=BCPHBM&rft_id=info:doi/10.1046/j.1365-2125.2003.01723.x&rft_dat=%3Cwiley_pubme%3EBCP1723%3C/wiley_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/12630972&rfr_iscdi=true